This article was downloaded by: [University of Jordan] On: 08 October 2011, At: 23:50 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK

Natural Product Research Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/gnpl20 Phytochemical screening and biological activities of spiculatum (Blume) Kuntze (family ) Fatma U. Afifi a & Rana Abu-Dahab b a Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Queen Rania Street, Amman 11942, Jordan b Department of Clinical Pharmacy, Faculty of Pharmacy, University of Jordan, Queen Rania Street, Amman 11942, Jordan Available online: 02 Aug 2011

To cite this article: Fatma U. Afifi & Rana Abu-Dahab (2011): Phytochemical screening and biological activities of (Blume) Kuntze (family Araceae), Natural Product Research, DOI:10.1080/14786419.2011.565558 To link to this article: http://dx.doi.org/10.1080/14786419.2011.565558

PLEASE SCROLL DOWN FOR ARTICLE

Full terms and conditions of use: http://www.tandfonline.com/page/terms-and- conditions This article may be used for research, teaching, and private study purposes. Any substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in any form to anyone is expressly forbidden. The publisher does not give any warranty express or implied or make any representation that the contents will be complete or accurate or up to date. The accuracy of any instructions, formulae, and drug doses should be independently verified with primary sources. The publisher shall not be liable for any loss, actions, claims, proceedings, demand, or costs or damages whatsoever or howsoever caused arising directly or indirectly in connection with or arising out of the use of this material. Natural Product Research 2011, 1–5, iFirst

SHORT COMMUNICATION Phytochemical screening and biological activities of Eminium spiculatum (Blume) Kuntze (family Araceae) Fatma U. Afifia* and Rana Abu-Dahabb

aDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Queen Rania Street, Amman 11942, Jordan; bDepartment of Clinical Pharmacy, Faculty of Pharmacy, University of Jordan, Queen Rania Street, Amman 11942, Jordan (Received 24 June 2010; final version received 19 February 2011)

Eminium spiculatum (Blume) Kuntze (Araceae) is an indigenous in Jordan used as an anticancer agent. The objective of this study was to determine the chemical composition of E. spiculatum and its antimicrobial, antiplatelet and antiproliferative activities. After isolation, antimicrobial activity was tested using well-in-agar method and in vitro platelet aggregation by aggrometric method. Antiproliferative activity was evaluated by Sulphorhodamine B assay. Luteolin, luteolin-7-O-glucoside, isoorientin, vitexin, chrysoeriol-7-O-glucoside and - sitosterol were isolated and their structures determined. Luteolin exhibited moderate antibacterial activity against Escherichia coli and resistant strains of Staphylococcus aureus in 1 mgmL1 concentration. Luteolin, luteolin-7-O-gluco- side and vitexin inhibited ADP and collagen-induced platelet aggregation in a concentration-dependent manner. For the determination of the antiproliferative activity, MCF-7 and T47D were used. Luteolin demonstrated the highest 1 inhibitory activity with IC50 values of 14.92 and 18.49 mmol L for MCF-7 and T47D, respectively. This research provided evidence about the chemical compo- sition and biological activity of E. spiculatum. Keywords: Eminium spiculatum; flavonoids; antimicrobial; antiproliferative; antiplatelet 1. Introduction Family Araceae is represented in Jordan by three genera and five species, namely palestinum Boiss., Arum dioscoridis Sm., Arum hygrophilum Boiss., angustatum (Hook. F.) N.E.Br. and Eminium spiculatum (Blume) Kuntze. In previous years, Downloaded by [University of Jordan] at 23:50 08 October 2011 A. palestinum was investigated in our laboratories and different flavone C-glycosides were isolated and their antimicrobial activities established (Afifi, Shervington, & Darwish, 1997). Recently, the antiproliferative activity of the same plant was evaluated using MCF- 7 and A549 cell lines (Abu Dahab & Afifi-Yazar, 2007). A literature survey indicated that no studies were carried out or published on E. spiculatum, the only representative of the Eminium grown wild in Jordan. The few published references (from 1967 to 1976) deal primarily with the amino acid and protein composition of this plant. The only report about the isolation of some flavonoids from the leaves of E. spiculatum grown in Greece dates back to 1988 (Shammas & Couladi, 1988).

*Corresponding author. Email: [email protected]

ISSN 1478–6419 print/ISSN 1478–6427 online ß 2011 Taylor & Francis http://dx.doi.org/10.1080/14786419.2011.565558 http://www.tandfonline.com 2 F.U. Afifi and R. Abu-Dahab

In the course of our search for active compounds of plant origin, this phytochemical and biological study with E. spiculatum was initiated with two aims: (1) to identify and isolate the constituents of this species; and (2) determine the antimicrobial, antiplatelet and antiproliferative activities of E. spiculatum for the crude extract, as well as for the isolated compounds. To the best of our knowledge, this is the first report on the screening of E. spiculatum for different biological activities.

2. Results and discussion Numerous studies describe the different biological activities of the flavonoids including antimicrobial, antioxidant, antiplatelet and anticancer activities. Flavonoids have been demonstrated to affect the activity of many mammalian enzyme systems in vitro and in vivo (Middleton, Kandaswami, & Theoharides, 2000). In this study, from the flowering aerial parts of E. spiculatum five flavonoids – one flavone aglycon (luteolin), two flavone- O-glucosides (luteolin-7-O-glucoside and chrysoeriol-7-O-glucoside) and two flavone- C-glucosides (vitexin and isoorientin) and -sitosterol were isolated using conventional column chromatography. The occurrence of vitexin, isoorientin, luteolin-7-O-glucoside and chrysoeriol-7-O-glucoside has been reported in an earlier study carried out with E. spiculatum grown in Greece (Shammas & Couladi, 1988). This is the first report of isolation of luteolin and -sitosterol from this species. The structures of the isolated compounds were determined using their physical properties and the different spectroscopic data (UV, IR, 1H-NMR, 13C-NMR). The obtained results were in agreement with the values reported for luteolin, luteolin- 7-O-glucoside, vitexin, isoorientin, chrysoeriol-7-O-glucoside and -sitosterol (Aggrawal, 1989; Gupta & Singh, 1991; Karioti, Skaltsa, Heilmann, & Sticher, 2003; Rabanal, Valverde, Martin-Lomas, Rodriguez, & Chari, 1982). For all isolated compounds, melting points and mixed melting points with the reference substances were determined and confirmed. No pronounced antibacterial activity was observed with either the crude extract or with the isolated compounds. Luteolin exhibited moderate antibacterial activity against Staphylococcus aureus in concentrations of 0.625 mg mL1, while negligible weak antibacterial activity (41mgmL1) was observed for vitexin and isoorientin. These findings are in agreement with those of Afifi et al. (1997) and Li, Henry, and Seeram (2009) and in contrast to those of Yamomoto and Ogawa (2002) and Kuete et al. (2008), who found that luteolin was potent against oral pathogenic bacteria and against Downloaded by [University of Jordan] at 23:50 08 October 2011 different pathogenic microorganisms. Luteolin-7-O-glucoside and chrysoeriol-7-O-gluco- side were inactive against all tested microorganism strains. The weak antibacterial activity observed can be explained by the absence of OH at C-3 of these flavonoids since it is well accepted that one of the main requirements of the antibacterial activity for the flavonoids is the presence of a free OH at C-3 (Mori, Nishino, Enoki, & Tawata, 1987). Table 1 shows the results of the antiplatelet activity of the ethanol extract and of the three isolated compounds, and their calculated IC50 values (experiments run in triplicates). For isoorientin and chryseriol-7-O-glucoside, due to the low amount of the isolated pure compounds, the single-point test was performed twice for ADP and collagen at concentrations of 0.037 mg mL1. At this concentration, chryseriol-inhibited aggregation of ADP by 63.8% and that of collagen by 39.5%. The least inhibition was observed with isoorientin (12.2%, 8.2% for ADP and collagen, respectively). Luteolin was the most potent compound in the inhibition of ADP-induced platelet aggregation while vitexin exhibited the highest potency in the inhibition of the collagen-induced platelet aggregation. Natural Product Research 3

Table 1. Biological activities of E. spiculatum crude extract and some of the isolated compounds.

Platelet aggregation inhibition Antiproliferative activity

1 1 1 IC50 (mg mL )IC50 (mgmL ) standard deviation (mmol L )

Collagen ADP MCF-7 T47D

Crude extract (E. spiculatum) 0.133 0.108 138 26.8 190 5.21 Luteolin 0.034 0.015 5.33 0.379, (18.49) 4.30 0.08, (14.92) Luteolin-7-O-glucoside 0.046 0.067 Non-toxic (0.1 and Non-toxic (0.1 and 100 mgmL1) 100 mgmL1) Vitexin 0.021 0.030 Non-toxic (0.1 and Non-toxic (0.1 and 100 mgmL1) 100 mgmL1) Isoorientin # # 135 15.3, (301.08) 49.8 3.17, (111.06) Chrysoeriol-7-O-glucoside # # 77.86 4.58, (168.53) 67.61 7.90, (146.34) -Sitosterol NT NT 61.85 4.7, (149.74) 39.02 10.3, (94.09) Cisplatin (mmol L1) 7.34 1.89 21.29 9.72 Doxorubicin (mmol L1) 0.16 0.02 0.17 0.03

1 Notes: The calculated IC50 values (mg mL ) in inhibiting the ADP and collagen-induced platelet aggregation and in vitro cytotoxicity activity (IC50 standard deviation) against MCF-7 and T47D cell lines after 72 h incubation. Results express average percentage standard deviation of six replicates done on at least two passages. # refers to text for single-point determination. NT, not determined.

Earlier, Lin, Kuo, Chung, Ko, and Teng (1997) reported that luteolin is more potent in the inhibition of arachidonic-acid induced aggregation than luteolin-7-O-glucoside and that isoorientin exhibited a weak antiplatelet effect. In another study, Dell’Agli et al. (2008) demonstrated an inhibitory effect of luteolin on human platelets. Similarly, in this study, luteolin was more potent than luteolin-7-O-glucoside in the inhibition of the ADP and collagen-induced platelet aggregation. The calculated IC50 values for luteolin were 0.015 1 and 0.034 mg mL for ADP and collagen, respectively. The calculated IC50 values obtained for its glycoside were 0.046 mg mL1 (collagen) and 0.067 mg mL1 (ADP). The observed inhibition was concentration dependent. Among the tested compounds, vitexin exhibited the highest potency in inhibiting the collagen-induced platelet aggregation with a 1 calculated IC50 value of 0.021 mg mL . It also yielded promising results in inhibiting the 1 ADP-induced aggregation (IC50 ¼ 0.030 mg mL ). Although not as potent as the pure compounds, the crude extact of E. spiculatum still influenced the ADP

Downloaded by [University of Jordan] at 23:50 08 October 2011 1 1 (IC50 ¼ 0.108 mg mL ) and collagen (IC50 ¼ 0.133 mg mL ) induced platelet aggregation. Sulphorohdamine cell proliferation assay was performed to test the possible cytotox- icity of the crude E. spiculatum extract and the isolated constituents. In this study, two breast adenocarcinoma cell lines were utilised to test the antiproliferative activity. Both cell lines are oestrogen receptor positive, well characterised and have been previously used for this purpose (Abu-Dahab & Afifi, 2007). Table 1 shows the IC50 values of the tested compounds and control drugs against breast cancer cell lines. According to the NCI, crude 1 extracts with IC50 values 30 mgmL were considered active (Boik, 2001). In our study, the crude extract of E. spiculatum did not exhibit any antiproliferative activity (IC50 value was above 100 mgmL1 for both cell lines). Luteolin is one of the flavonoids with reported anti-tumour activies (Leung, Kuo, Yang, Lin, & Lee, 2006). Here, it exhibited a potent antiproliferative activity with an IC50 as low as 14.92 and 18.49 mmol L1 for T47D and MCF-7, respectively. The observed potency for luteolin is in agreement with the reported GS-X (glutathione conjugate) pump inhibition potency for this flavonoid (van Zanden et al., 2004). The other tested 4 F.U. Afifi and R. Abu-Dahab

components were not toxic in the concentration ranges tested. Higher cocentrations were not tested since this would increase the percentage of DMSO and an accurate assessment of the activity would not be possible. The antiproliferative activity of luteolin was comparable to that of cisplatin for T47D cell line, while its isolated glycoside did not exhibit any antiproliferative activity against MCF-7 and T47D at tested concentrations (Table 1).

3. Conclusion Despite the advances in synthetic chemistry, medicinal , used in the traditional medicine of different cultures, challenge the phytochemists involved in the search of bioactive substances. This research has provided evidence about the chemical composition and antimicrobial, antiplatelet and antiproliferative effects of E. spiculatum and its constituents. Luteolin should be further evaluated since it exhibited promising antiproliferative activity towards the tested breast cancer cell lines.

Supplementary material Experimental details relating to this article are available online.

Acknowledgement This study was supported by a grant (no. UJ 1082) of the Deanship of Academic Research, University of Jordan during the author’s sabbatical leave. Miss Lara Majdalawi, Miss Ghadeer Othman, Mr Ismail Abaza and Mr Ameed Taher are thanked for their technical assistance.

References

Abu-Dahab, R., & Afifi, F. (2007). Antiproliferative activity of selected medicinal plants of Jordan against a breast adenocarcinoma cell line (MCF7). Scientia Pharmaceutica, 75, 121–136. Afifi, F.U., Shervington, A., & Darwish, R. (1997). Phytochemical and biological evaluation of Arum palaestinum. Part 1: Flavone C-glycosides. Acta Technologiae et Legis Medicamenti, VIII, 105–111. Aggrawal, P.K. (1989). Carbon -13 NMR of flavonoids: Studies in organic chemistry 39. Amsterdam: Elsevier. Boik, J.C. (2001). Natural compounds in cancer therapy. Prince Town: MN: Oregon Medical Press. Dell’Agli, M., Maschi, O., Galli, G.V., Fagnani, R., Dal Cero, E., Caruso, D., & Bosisio, E. (2008). Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. British Journal of Nutrition, 99, 945–951. Gupta, D., & Singh, J. (1991). Flavonoid glycosides from Cassia alata. Phytochemistry, 30, 2761–2763.

Downloaded by [University of Jordan] at 23:50 08 October 2011 Karioti, A., Skaltsa, H., Heilmann, J., & Sticher, O. (2003). Acylated flavonoid and phenylethanoid glycosides from Marrubium velutinum. Phytochemistry, 64, 655–660. Kuete, V., Ngameni, B., Simo, C.C., Tankeu, R.K., Ngadjui, B.T., Meyer, J.J., ..., Kuiate, J.R. (2008). Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae). Journal of Ethnopharmacology, 120, 17–24. Leung, H.W., Kuo, C.L., Yang, W.H., Lin, C.H., & Lee, H.Z. (2006). Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. European Journal of Pharmacology, 534, 12–18. Li, L., Henry, G.E., & Seeram, N.P. (2009). Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliulata seeds. Journal of Agricultural and Food Chemistry, 57, 7282–7287. Lin, C.N., Kuo, S.H., Chung, M.I., Ko, F.N., & Teng, C.M. (1997). A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis. Journal of Natural Products, 60, 851–853. Middleton Jr, E., Kandaswami, C., & Theoharides, T.C. (2000). The effect of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacology Review, 52, 673–751. Mori, A., Nishino, C., Enoki, N., & Tawata, S. (1987). Antibacterial activity and mode of action of plant flavonoids against Proteus vulgaris and Staphylococcus aureus. Phytochemistry, 26, 2231–2234. 00 Rabanal, R.M., Valverde, S., Martin-Lomas, M., Rodriguez, B., & Chari, M. (1982). Chrysoeriol 7-(2 -O- -D- allopyrnosyl)- -D-glucopyranoside from Sideritis grandiflora. Phytochemistry, 21, 1830–1832. Natural Product Research 5

Shammas, G., & Couladi, M. (1988). On the constituents of the leaves of Eminium spiculatum (Blume) Schott. Scientia Pharmaceutica, 56, 271–281. van Zanden, J.J., Geraets, L., Wortelboer, H.M., van Bladeren, P.J., Rietjens, I.M.C.M., & Cnubben, N.H.P. (2004). Structural requirements for the flavonoid-medieted modulation of glutathion S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochemistry and Pharmacology, 67, 1607–1617. Yamomoto, H., & Ogawa, T. (2002). Antimicrobial activity of Perilla seed polyphenols against oral pathogenic bacteria. Bioscience Biotechnology and Biochemistry, 66, 921–924. Downloaded by [University of Jordan] at 23:50 08 October 2011